T-Cell Acute Lymphocytic Leukemia
3 clinical trials · Condition
◉ Watch T-Cell Acute Lymphocytic Leukemia
| Record | Firm | Date |
|---|---|---|
| A Multicenter, Open-Label, Non-Randomized, Single-Arm Clinical Study of Nanobody CD5-CAR T Cell Therapy for Refractory/Relapsed T Lymphocyte Malignancies (NCT07070323) | Beijing GoBroad Hospital | 2025-07-09 |
| CD5 Chimeric Antigen Receptor (CAR) T Cells in Subjects With Relapsed or Refractory T-cell Malignancies (NCT06316856) | Beijing GoBroad Hospital | 2024-06-18 |
| A Clinical Study of CAR-T Treating Relapsed or Refractory T Cell Lymphoblastic Acute Leukemia/ Lymphoma (NCT05909527) | Guangzhou Bio-gene Technology Co., Ltd | 2023-05-01 |
Track T-Cell Acute Lymphocytic Leukemia automatically
Every clearance here is in the API, with alerts when new ones post.